Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...

Scholar Rock stock rises on optimism for FDA approval of apitegromab in spinal muscular atrophy. Read more here.

Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has ...

While biologics are expected to drive CDMO growth through 2033, foreign exchange rates and tariffs are looming challenges.

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

Denis Johnson became CEO on Sept. 1 at the Grand Rapids-based contract manufacturer Grand River Aseptic Manufacturing.

The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...

The Danish pharmaceutical company Novo Nordisk is cutting 9,000 jobs, 4,000 of which will be outside Denmark. The company, one of Bloomington’s major employers, did not comment on whether any jobs at ...

据路透社援引两位“直接参与讨论”的投资人士称，艾兰得公司已经聘请高盛在中美两地同时接洽战略买家与PE基金，但尚未设定接收非约束性报价的截止日期。据此，外界猜测该计划仍处于早期阶段。

In-vitro toxicology testing market was valued at US$ 26.00 billion in 2024 and is projected to hit the market valuation of US$ 57.55 billion by 2033 at a CAGR of 9.23% during the forecast period ...

"Browse 422 market data Tables and 57 Figures spread through 380 Pages and in-depth TOC on "Biopharmaceutical CDMO Market - Global Forecasts to 2030" Global biopharmaceutical contract manufacturing ...

近日，据《金融时报》报道，伦敦私募股权公司 Permira 正计划出售其旗下的合同开发与制造组织（ CDMO ） Cambrex ，交易估值有望达到 40 亿美元。这一消息不仅引发市场广泛关注，也再次点燃了全球资本对 CDMO 赛道的热情。